(Q42981169)

English

Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.

scientific article published on 13 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Laila Al Shaer

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mahera AbdulRahman

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Thomas J John

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ali AlHashimi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

13 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2300-2309

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Nucleic acid testing (NAT) in high prevalence-low resource settings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Chronic hepatitis B virus infection in Asian countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

[Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

First report of human immunodeficiency virus transmission via an RNA-screened blood donation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Epidemiology and Prevention of Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Italian blood donors with anti-HBc and occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03740.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2012.03740.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42981169&oldid=1590629986"